Functional dyspepsia: Time to change clinical trial design?

American Journal of Gastroenterology

Volumn 105, Issue 12, 2010, Pages 2525-2529

  Lacy, Brian E ^a   Talley, Nicholas J ^b   Camilleri, Michael ^c  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DESIPRAMINE; PREGABALIN; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; VENLAFAXINE;

CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DYSPEPSIA; EPIGASTRIC PAIN; FUNCTIONAL DYSPEPSIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; REVIEW; SATIETY; SCINTIGRAPHY; STOMACH EMPTYING; STUDY DESIGN; VISCERAL PAIN;

BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; DYSPEPSIA; ENDPOINT DETERMINATION; HUMANS; QUESTIONNAIRES; RESEARCH DESIGN;

EID: 78649870627     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.266     Document Type: Review

References (43)

1. Nyren O, Lindberg G, Lindstrom E et al. Economic costs of functional dyspepsia. Pharmaco-economics 1992;1:312-24.
2. El Serag HB, Talley NJ. Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ter 2003;18:387-93.
3. Weiser KT, Kennedy AT, Lacy BE et al. Functional dyspepsia: the economic impact to patients. Annual Meeting of the American College of Gastroenterology, Philadelphia, PA, 12-17 October 2007.
4. Aro P, Talley NJ, Ronkainen J et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III) criteria in a Swedish population-based survey. Gastroenterology 2009;137:94-100.
5. Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-79.
6. Castillo EJ, Camilleri M, Locke GR et al. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol 2004;2:985-96.
7. Choung RS, Locke GR, Schleck CD et al. Do distinct dyspepsia subgroups exist in the community? A population-based study. Am J Gastroenterol 2007;102:1983-9.
8. Bisschops R, Karamanolis G, Arts J et al. Relationship between symptoms and inges-tion of a meal in functional dyspepsia. Gut 2008;57:1495-503.
9. Tack J, Caenepeel, P, Fischler B et al. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenter-ology 2001;121:526-35.
10. Mertz H, Fass R, Kodner A et al. Efect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998;93:160-5.
11. Drossman DA, Toner BB, Whitehead WE et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology 2003;125:19-31.
12. Hojo M, Miwa H, Yokoyama T et al. Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. J Gastroenterol 2005;40:1036-42.
13. Van Kerkhoven LAS, Laheij RJF, Aparicio N et al. Efect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroen-terol Hepatol 2008;6:746-52.
14. Tack J, Piessevaux H, Coulie B et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998;115:1346-52.
15. Sarnelli G, Caenepeel P, Geypens B et al. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003;98:783-8.
16. Lacy BE, Cash BD. A 32-year-old woman with chronic abdominal pain. JAMA 2008;299:555-65.
17. Veldhuyzen van Zanten SJ, Jones MJ, Verlinden M et al. Efcacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am J Gastroenterol 2001;96:689-96.
18. Moayyedi P, Soo S, Deeks J et al. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2003;CD001960.
19. Saad RJ, Chey WD. Review article: current and emerging therapies for functional dyspepsia. Aliment Pharmacol Ter 2006;24:475-92.
20. Van Lelyveld N, Schipper M, Samsom M. Lack of relationship between chronic upper abdominal symptoms and gastric function in functional dyspepsia. Dig Dis Sci 2008;53:1223-30.
21. Fruehauf H, Steingoetter A, Fox MR et al. Characterization of gastric volume responses and liquid emptying in functional dyspepsia and health by MRI or barostat and simultaneous 13C-acetate breath test. Neurogastroenterol Motil 2009;21:697-708.
22. Fidler J, Bharucha AE, Camilleri M et al. Ap -plication of magnetic resonance imaging to measure fasting and postprandial volumes in humans. Neurogastroenterol Motil 2009;21:42-51.
23. De Schepper HU, Cremonini F, Chitkara D et al. Assessment of gastric accommodation: overview and evaluation of current methods. Neurogas-troenterol Motil 2004;16:275-85.
24. Odunsi ST, Camilleri M. Selected interventions in nuclear medicine: gastrointestinal motor functions. Semin Nucl Med 2009;39:186-94.
25. Moayyedi P, Soo S, Deeks J et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;CD002096.
26. Wang WH, Huang JQ, Zheng GF et al. Efects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol 2007;5:178-85.
27. Delgado-Aros S, Camilleri M, Cremonini F et al. Contributions of gastric volumes and gastric emptying to meal size and post-meal symptoms in functional dyspepsia. Gastroenterology 2004;127:1685-94.
28. Castillo EJ, Camilleri M, Locke GR III et al. A community based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol 2004;2:985-96.
29. Delgado-Aros S, Camilleri M, Castillo EJ et al. Efect of gastric volume or emptying on meal-related symptoms afer liquid nutrients in obesity: a pharmacological study. Clin Gastroen-terol Hepatol 2005;3:997-1006.
30. Van Oudenhove L, Vandenberghe J, Geeraerts B et al. Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation? Gut 2008;57:1666-73.
31. Bouras EP, Delgado-Aros S, Camilleri M et al. SPECT imaging of the stomach: comparison with barostat and efects of sex, age, body mass index, and fundoplication. Gut 2002;51:781-6.
32. Chial HJ, Camilleri C, Delgado-Aros S et al. A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: efects of gender, body mass index and age in health. Neurogastroenterol Motil 2002;14:249-53.
33. Kindt S, Dubois D, van Oudenhove L et al. Relationship between symptom pattern, assessed by the PAGI-SYM©questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia. Neurogastroenterol Motil 2009;21:1183-e105.
34. Abell TL, Camilleri M, Donohoe K et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the Society of Nuclear Medicine and the American Neurogastroenterology and Motility Society. Am J Gastroenterology 2008;103:753-63.
35. Szarka LA, Camilleri M, Vella A et al. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol 2008;6:635-43.
36. Odunsi ST, Camilleri M, Szarka LA et al. Optimizing analysis of stable isotope breath tests to estimate gastric emptying of solids. Neurogastroenterol Motil 2009;21:706-38.
37. Veldhuyzen van Zanten SJ, Chiba N, Armstrong D et al. Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials. Aliment Pharmacol Ter 2006;23:521-9.
38. Fraser A, Delaney B, Moayyedi P. Symptom-based outcome measures for dyspepsia and GERD trials: a systematic review. Am J Gastroenterol 2005;100:442-52.
39. Jones M, Talley NJ. Minimum clinically important diference for the Nepean Dyspepsia Index, a validated quality of life scale for functional dyspepsia. Am J Gastroenterol 2009;104:1483-8.
40. Talley NJ, Verlinden M, Jones M. Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. Aliment Pharmacol Ter 2001;15:207-16.
41. Kulich KR, Madisch A, Pacini F et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Refux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes 2008;6:12.
42. Fraser A, Delaney BC, Ford AC et al. The short-form Leeds Dyspepsia Questionnaire validation study. Aliment Pharmacol Ter 2007;25:477-86.
43. Moayyedi P, Dufett S, Braunholtz D et al. The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ter 1998;12:1257-62.